Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Barrier Therapeutics reports positive results from phase II study of oral antihistamine Hivenyl

April 14, 2008

New wound-healing agents described in recent Hokkaido University and Shionogi patent

April 14, 2008

Biofrontera presents update on phase III studies of BF-200 ALA in actinic keratosis

April 9, 2008

Hana starts phase I topical menadione trial for EGFR inhibitor-associated rash

April 8, 2008

Cosmo begins phase I trials of anti-androgen cream as skin disorder therapy

April 4, 2008

Recent Dainippon Sumitomo patent describes novel therapeutic agents for dermatitis

April 4, 2008

DUSA completes enrollment in phase IIb trial of Levulan photodynamic therapy for acne

April 2, 2008

BioMimetic Therapeutics responds to FDA communication on Regranex safety review

April 2, 2008

MPA requests additional information prior to initiation of Tripeps' ChronSeal phase II study

April 1, 2008

Anacor announces positive results from phase IIa trial of AN-2728 in psoriasis patients

March 26, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...